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Introduction
The goal of radiotherapy is to deliver the dose precisely to
the target volume leaving the healthy tissues spared. With
a new modality of three-dimensional conformal radio-
therapy (3D-CRT) – intensity modulated radiation thera-
py (IMRT) – maintaining low level treatment toxicity wi-
thin the cristical organs and increasing total tumor dose
becomes more likely. [1, 2]. The idea behind IMRT is to
create a set of static fields with multileaf collimator leaves
(MLC) moving while the beam is on. Thus the shape of
the irradiated field changes during irradiation. In conven-
tional radiotherapy “flat” intensity fields are applied. In
IMRT such fields are replaced by “non uniform” intensi-
ty modulated beams.
IMRT combines two concepts of 3D CTR delive-
ry: inverse treatment planning with computer optimiza-
tion and computer controlled intensity modulation of
the beam during the treatment. Due to high conformali-
IMRT in clinical practice – introduction of new QA procedures
Agata Rembielak, Krzysztof Âlosarek,
Aleksandra Grzàdziel, Bogus∏aw Maciejewski1
The goal of radiotherapy is to deliver the dose precisely to the target volume leaving the healthy tissues spared. With a new mo-
dality of three-dimensional conformal radiotherapy (3D-CRT) – intensity modulated radiation therapy (IMRT) – maintaining
low level treatment toxicity within the critical organs and increasing total tumor dose becomes more likely.
IMRT combines two concepts of 3D-CRT delivery: inverse treatment planning with computer optimization and computer con-
trolled intensity modulation of the beam during the treatment. Due to high conformality of IMRT plans it is very important to
develop proper quality assurance (QA) protocols for treatment planning and to implement them in clinical practice.
In the Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology at Gliwice, Poland an IMRT planning sys-
tem CadPlan-Helios (Varian) has been in use since October 2000. Treatment is delivered by four accelerators: two Clinac 2300
and two Clinac 600, all equipped with dynamic multileaf collimator option (dMLC).
The aim of this paper is to present our experiences with the IMRT technique implementation in clinical practice with particu-
lar regard to new quality assurance procedures.
Nowe procedury kontroli jakoÊci w radioterapii
z modulacjà intensywnoÊci wiàzki
Celem planowania leczenia w radioterapii jest dostarczenie mo˝liwie wysokiej dawki promieniowania w obszar guza z jedno-
czesnà maksymalnà ochronà tkanek zdrowych. Nowa technika w radioterapii – modulacja intensywnoÊci wiàzki (IMRT) –
pozwala na utrzymanie niskiego ryzyka powik∏aƒ ze strony narzàdów krytycznych przy eskalacji dawki w obszarze guza.
IMRT ∏àczy w sobie dwie koncepcje konformalnej radioterapii: odwrotne planowanie leczenia i komputerowà optymalizacj´
oraz komputerowo sterowanà modulacj´ intensywnoÊci wiàzki podczas napromieniania. Ze wzgl´du na bardzo du˝à precy-
zj´, jakà narzuca na u˝ytkownika IMRT, konieczne jest opracowanie i wdro˝enie w praktyce klinicznej szczegó∏owych proce-
dur kontroli jakoÊci radioterapii (QA).
W Centrum Onkologii – Instytucie w Gliwicach IMRT zosta∏a po raz pierwszy zastosowana w paêdzierniku 2000 roku.
Planowanie IMRT jest przeprowadzane za pomocà systemu CadPlan-Helios, natomiast leczenie za pomocà dwóch akcele-
ratorów Clinac 2300 i dwóch Clinac 600; wszystkie wyposa˝one w opcj´ dynamicznego kolimatora wielolistkowego (dMLC).
Celem pracy jest przedstawienie kolejnych etapów planowania i leczenia w oparciu o modulacj´ intensywnoÊci wiàzki ze szcze-
gólnym uwzgl´dnieniem nowych procedur kontroli jakoÊci w IMRT, zwiàzanych z weryfikacjà prowadzonego napromienia-
nia.
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ty of IMRT plans it is very important to develop proper
quality assurance (QA) protocols for treatment planning
process and their implementation in clinical practice
[3, 4].
The aim of this paper is to present the steps of IMRT
planning and application in clinical practice with particu-
lar regard to new QA procedures for treatment verifica-
tion (electronic portal imaging, independent treatment
time calculations) [1, 5, 6].
IMRT in the Maria Sk∏odowska-Curie Memorial
Cancer Center and Institute of Oncology, Gliwice,
Poland
The Maria Sk∏odowska-Curie Memorial Cancer Center
and Institute of Oncology at Gliwice, Poland has been
using the IMRT planning system CadPlan-Helios (Va-
rian) since October 2000. Over 60 patients have already
been treated (head and neck cancers, prostate, lung, bra-
in, rectum, retroperitoneal space tumors). The Radio-
therapy Department in Gliwice is equipped with two Cli-
nac 2300 accelerators, two Clinac 600 accelerators (Va-
rian) and two cobalt units. Dynamic MLC option is
installed in all Clinac accelerators. Cadplan-Helios pro-
gram computers and accelerators are connected via
VARiS Management System. IMRT computer treatment
planning process includes visualization with contour defi-
nition, beam geometry set-up, dose calculations, treat-
ment and verification. The detailed steps of IMRT plan-
ning procedures are shown in Figure 1.
The new concept of IMRT is inverse planning (com-
puter optimization function), thus differing from conven-
tional radiotherapy
C o n t o u r  d e f i n i t i o n
Exact contouring is critical for precise treatment plan-
ning. In the IMRT technique particular impact is put on
the Planning Target Volume (PTV) definition due to very
high conformity of the treatment. Cristical structures
must also be contoured in order to control and minimize
the risk of treatment complications.
B e a m  g e o m e t r y  s e t - u p
The treatment planner selects various field sizes and the
beam angle and its weight to irradiate the specific tumor
volume. The dose contributions to the target, and to other
organs, are evaluated by the planner and used to choose
optimal combination of the beams. In IMRT planning
the beam set-up is based on our experience gathered on
non-conformal and conformal planning. The CadPlan-
-Helios requires a number of fields, beam directions and
beam energy to be selected by the planner. Due to non-
-uniform IMRT beams one should avoid opposing fields
and creating non-coplanar beam set-up.
O p t i m i z a t i o n  p r o c e s s
Before starting the optimization program, organ con-
straints and optimization parameters must be specified.
Basing on pre-defined parameters the CadPlan-Helios
generates leaf motion patterns, produces the actual flu-
ence map and animates dMLC delivery. The set of dose
constraints covers minimum and maximum doses for
particular volumes and dose-volume restrictions. The
definition of dose constraints bases on clinical experien-
ce, but radiobiological data should also be considered.
Organ constraints are determined individually for each
patient. In the CadPlan-Helios there is a possibility to
memorise constraints and reload them for other patients,
however the definition of constraints for the volume of
interest constitutes a very individual part of the treat-
ment.
Optimization parameters are:
– priority factor (specifies the clinical significance of do-
se limits for a particular structure)
– scatter distance (determines the matrix scatter taken
into account in computer calculations)
– termination tolerance (automatic stop value for optimi-
zation function)
– maximum number of iterations
D o s e  c a l c u l a t i o n s
Computer dose calculations are performed by the
Cadplan-Helios treatment planning system v. 6. 1. 5 (Va-
rian).
P l a n  a p p r o v a l  a n d  d a t a  e x p o r t
The final treatment plan presented by the computer is
approved by a physicist. Next treatment data are enetered
into the VARiS Management System connected via ne-
twork to the accelerators.
Tr e a t m e n t  ( d y n a m i c  M L C  o p t i o n )
Treatment is performed on a Clinac accelerator equipped
with dMLC option version 5.4.
Figure 1. IMRT treatment planning process
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Tr e a t m e n t  v e r i f i c a t i o n
Treatment verification (Figure 2) is performed on two
levels: graphic and dosimetric. Some verification procedu-
res (e.g. treatment time and isocenter location) are con-
ducted before the treatment, some already on the accele-
rator. The number of monitor units (MU) is calculated by
the treatment planning system. While the verification of
these values is performed by an independent MU calcula-
tion program named Winczas® (Figure 4) originally desi-
gned in our Institute and successfully utilized in routine
clinical practice. The main objective of independent calcu-
lation is to find the major errors in field size or beam
energy. The Cadplan-Helios calculations still remain the
basis for treatment. All IMRT patient data are stored in
a database, which allows to analyze differences in MU
between CadPlan-Helios and Winczas® for particular pa-
tients and/or for all patients.
The isocenter control is conducted every day prior to
the actual treatment. In order to verify the isocenter posi-
tion (the control of patient positioning) two geometri-
cally identical orthogonal (0° and 90°) images are taken
during the real treatment and compared with correspon-
ding images taken during simulation [6].
Localization port films are obtained for each intensi-
ty modulated field with the MLC set to the “start” posi-
tion of the leaves and consecutive leaves positions till the
“stop” position. The image sequence verification allows to
compare consecutive segments of MLC leaves position
calculated by CadPlan-Helios with corresponding seg-
ment images obtained by electronic portal imaging (Figu-
re 3). This procedure verifies that the radiation is proper-
ly directed (relative to the bony structures) and modu-
lated by MLC leaves. Although such verification is
time-consuming it is also of crucial value [5, 7-9].
IMRT is a time-consuming process; it begins with
contour definition and ends with treatment verification.
Thus all indications for IMRT must be carefully consi-
dered [10, 11]. On the other hand it allows for a “sculptu-
Figure 2. IMRT – verification of the treatment
Figure 4. WinCzas®- independent MU calculation program
Figure 3. Comparison of segments calculated by the CadPlan-Helios
and obtained from electronic portal imaging
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re” of dose distribution in 3D and the results are a worthy
reward for the time spent (Figure 5).
Summary
IMRT opens new possibilities before radiation oncolo-
gy:
– treatment of previously inaccessible areas (better pa-
tient safety)
– better protection of normal tissues
– dose escalation to the selected structures
IMRT requires new ways of thinking during the planning
process (inverse planning with optimization), new organi-
zation of the routine workday in radiotherapy depart-
ments and more precise verification on each level of plan-
ning and treatment.
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Figure 5. Example of IMRT dose distribution (PTV – Planning Target
Volume, OR – Organ at Risk, here: spinal cord)
